Also, a member of the ADP-ribosylation factor GTPase-activating protein family, AGAP1, was found up-regulated both in rapid progression patients and in LUHMES cells treated with MPP+, suggesting that cytoskeleton dynamics, and membrane trafficking may be important processes in PD. Here, AGAP1 is linked to Parkinson disease.